New diabetes pill tested for safety in early human trial
NCT ID NCT00707954
Summary
This early-stage study tested a new oral medication called TA-7284 for type 2 diabetes. Researchers gave 61 patients with diabetes increasing doses of the drug over 15 days to check its safety and how the body processes it. The study measured blood sugar levels and other diabetes markers to see if the drug had any effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
P-One Clinic
Hachiōji, Tokyo-to, Japan
Conditions
Explore the condition pages connected to this study.